Representatives from the Chinese side say they think it likely that Chinese President Xi Jinping will attend the G-20 meeting later this month. But in order to reach a trade...China Economyread more
Software engineers straight out of college often make six-figure salaries, not counting equity compensation.Technologyread more
Wall Street, though, is clamoring for a rate cut, with an 85% chance of a move in July and a 61% probability of three reductions by year's end.The Fedread more
A company spokesperson said the outage was the result of a "an internal technology issue" and was not security related.Retailread more
The flattening of the yield curve is exuding a bad omen for the stock market if history is any guide.Marketsread more
Using MIT's living wage calculator, CNBC Make It mapped out the minimum amount a single parent must earn to meet their basic needs without relying on outside help in every...Earnread more
Hong Kong Chief Executive Carrie Lam announced at a press conference on Saturday that a contentious bill to allow extraditions to mainland China has been put on hold.China Politicsread more
Stratolaunch, the world's largest airplane, which flew once, is up for sale, sources familiar told CNBC.Investing in Spaceread more
Transparency is key… or is it? With the first-ever non-transparent, actively managed exchange-traded fund receiving approval from the SEC, "ETF Edge" goes straight to the...ETF Edgeread more
Mired in a crisis over its best-selling 737 Max plane, Boeing could hand the spotlight over to its rival Airbus at the Paris Air Show.Airlinesread more
A new update to the Apple Watch called watchOS 6 will notify you if the environment you're in is too loud and could damage your hearing.Technologyread more
Royal Caribbean: "People are too worried about raw costs. They're too worried about the idea that there are too many ships coming on. They're wrong. I think it's a buy."
Allergan Plc: "I have said that that has been my worst stock in about a decade. I still would like to believe, but it is just not acting well and I'm not going to tell you to buy any more here."
Tyson Foods, Inc.: "I think the stock's come down a lot, but I have no catalysts and people did not like that last quarter, to be candid. I hesitate to go where everybody else is fleeing in that food group. It's so darned hard. So I'm not going to pull the trigger here."
Carrizo Oil & Gas: "It's too late, unless oil's going to go to $90. Carrizo had this incredible move, raised some capital. Really well-run company. I wish they'd come back on. They're smarter than the average bear in oil, but you know what? As much as I'm bullish on the management, I have to say don't buy because of the incredible move."
Valeant Pharmaceuticals International: "No, [don't ring the register]. [CEO] Joe Papa's doing a great job. Now, it is not going to run fast, OK? But it has had a great move, Joe is doing so much good, he's got a good pipeline, fixing the balance sheet, got 'em out of legal trouble. I can't tell you to take profits. I think it could still go higher."
Okta, Inc.: "I can't tell you to pull the trigger. It's up almost 100 percent. It's a very good company, but that is way too much for me to be able to come in and say buy, so I'm going to say hold."
Crispr Therapeutics: "Oh jeez, it's another one that has just run so much. I know this is going to sound like I've gotten bearish, but here's a stock that's up 175 percent. I'm not saying this ship has sailed. I am saying that it would be irresponsible for me to come in and say now is the time to buy Crispr, so I'm not going to do that."
Walgreens Boots Alliance, Inc.: "I think it's too low to sell. My inclination is much more to be a buyer down here than a seller. I think that it's overly hated, so I am going to say buy, buy, buy."
The Southern Company: "Southern's come down too much, as has Dominion. I just gave you a two-fer. Both of those are down too much and they presume interest rates are going to 3.5 [percent] immediately. That's the 10-year. I don't think so. "